These findings establish a correlation between ADAM17 and Notch signaling, which has been previously reported in various diseases, including prostate tumors, non–small cell lung carcinoma, hepatocellular carcinoma, and diabetic nephropathy (55–57). Here, ADAM17 is linked to diabetic kidney disease.